75% of lung cancer cases are detected too late. OncoSwab is changing that. Our mission: make early detection accessible with a non-invasive, easy-to-use test.
Founded by visionary scientists and supported by the Health Wildcatters Accelerator, Swiss Government's DayOne Tech, and several pre-seed investors, OncoSwab is currently conducting a proof-of-concept trial with the collaboration of top US and European hospitals and lung cancer experts, aiming to save lives worldwide.
OncoSwab has offices in San Francisco, California and Corroux, Switzerland.
Company Details
- Employees
- 7
- Founded
- -
- Address
- And Asked Him Why Such An Approach Didn’t Exist Already.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://oncoswab.com
- Keywords
- Zürich.
Oncoswab Questions
Oncoswab's website is http://oncoswab.com
Oncoswab's LinkedIn profile is https://www.linkedin.com/company/oncoswab
Oncoswab has
7 employees.
View email and phone details for 7
employees at Oncoswab.
Oncoswab's industry is
Biotechnology Research
Oncoswab's top competitors are
Onetwenty.ai,
Aimorphous Health,
Apersys Ag,
Orthosens,
Mynerva Ag,
Metadvice,
Aseptuva,
Bios Medical,
Calico Biosystems,
Impli.
Oncoswab's categories are Biotechnology Research
Oncoswab's founding year is 2023
